No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 Diabetes
Todd M. Brusko(University of Florida), Mark A. Atkinson(University of Florida), Desmond Schatz(University of Florida), Michael J. Haller(University of Florida), Kieran McGrail(University of Florida), Jennifer Rockell(University of Colorado Health), Peter A. Gottlieb(University of Colorado Health), Clive Wasserfall(University of Florida), Michael Clare‐Salzler(Montreal Neurological Institute and Hospital), Richard A. Schatz(Northwestern University), Hilla Lee Viener(University of Florida)
Cited by 253
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k